Clinical Research Directory
Browse clinical research sites, groups, and studies.
The APRIL Trial Evaluating Upfront Stereotactic Body Radiotherapy in Stage III Advanced Non-small Cell Lung Cancer
Sponsor: All India Institute of Medical Sciences
Summary
The aim of the study is to test the feasibility \& loco-regional control rate by combining high precision SBRT with chemotherapy in stage III NSCLC in tumor/lymph nodes if tumors/lymph node size with ≤ 6cms in size.
Official title: The APRIL Trial: A Phase II Trial Evaluating Upfront Stereotactic Body Radiotherapy in Stage III Advanced Non-small Cell Lung Cancer
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-12-19
Completion Date
2029-12-18
Last Updated
2026-09-11
Healthy Volunteers
Yes
Conditions
Interventions
SBRT in stage III NSCLC
SBRT to primary tumor and lymph nodes in stage III NSCLC when gross disease is \< 6 cms
Locations (1)
Nci, Aiims-Jhajjar
Jhajjar, Haryana, India